Search research articles
Contact Us
Filters
Showing results (21-30 of 79) with videos related to
Page
of 8
Sort By:
Pain Practice : the Official Journal of World Institute of Pain
|
September 13, 2017
Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation
Lynn Webster, Ulysses Diva, Raj Tummala, et al.
Drugs & Aging
|
February 23, 2020
Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age
James Wild, Lynn Webster, Tadaaki Yamada, et al.
Journal of Opioid Management
|
November 5, 2010
A double-blind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain
Lynn Webster, Patricia Richards, Warren Stern, et al.
Journal of Clinical Pharmacology
|
March 4, 2024
Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone
Mark Ellison, Emily Hutton, Lynn Webster, et al.
Journal of Addictive Diseases
|
June 9, 2016
Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial
Lynn Webster, Peter Hjelmström, Michael Sumner, et al.
Journal of Clinical Pharmacology
|
July 23, 2016
Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog Scales
Beatrice Setnik, Carl L Roland, Glenn Pixton, et al.
Pain Medicine (Malden, Mass.)
|
April 6, 2011
The abuse potential of Remoxy(®), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodone
Beatrice Setnik, Carl L Roland, Jody M Cleveland, et al.
Current Medical Research and Opinion
|
October 9, 2018
Extended-release morphine sulfate and naltrexone hydrochloride (EMBEDA): naltrexone-associated withdrawal and abuse-related effects in patients with chronic pain and recreational opioid users
Beatrice Setnik, Kenneth W Sommerville, Glenn C Pixton, et al.
Spine
|
May 16, 2017
Treatment Options for Failed Back Surgery Syndrome Patients With Refractory Chronic Pain: An Evidence Based Approach
Kasra Amirdelfan, Lynn Webster, Lawrence Poree, et al.
Journal of Pain Research
|
August 14, 2025
Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative Review
Lynn Webster, Jeff Gudin, Jody L Green, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 79) with videos related to
Sort By:
Page
of 8
Pain Practice : the Official Journal of World Institute of Pain
|
September 13, 2017
Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation
Lynn Webster, Ulysses Diva, Raj Tummala, et al.
Drugs & Aging
|
February 23, 2020
Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age
James Wild, Lynn Webster, Tadaaki Yamada, et al.
Journal of Opioid Management
|
November 5, 2010
A double-blind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain
Lynn Webster, Patricia Richards, Warren Stern, et al.
Journal of Clinical Pharmacology
|
March 4, 2024
Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone
Mark Ellison, Emily Hutton, Lynn Webster, et al.
Journal of Addictive Diseases
|
June 9, 2016
Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial
Lynn Webster, Peter Hjelmström, Michael Sumner, et al.
Journal of Clinical Pharmacology
|
July 23, 2016
Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog Scales
Beatrice Setnik, Carl L Roland, Glenn Pixton, et al.
Pain Medicine (Malden, Mass.)
|
April 6, 2011
The abuse potential of Remoxy(®), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodone
Beatrice Setnik, Carl L Roland, Jody M Cleveland, et al.
Current Medical Research and Opinion
|
October 9, 2018
Extended-release morphine sulfate and naltrexone hydrochloride (EMBEDA): naltrexone-associated withdrawal and abuse-related effects in patients with chronic pain and recreational opioid users
Beatrice Setnik, Kenneth W Sommerville, Glenn C Pixton, et al.
Spine
|
May 16, 2017
Treatment Options for Failed Back Surgery Syndrome Patients With Refractory Chronic Pain: An Evidence Based Approach
Kasra Amirdelfan, Lynn Webster, Lawrence Poree, et al.
Journal of Pain Research
|
August 14, 2025
Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative Review
Lynn Webster, Jeff Gudin, Jody L Green, et al.
Page
of 8